Skip to main content

Market Overview

17 Healthcare Stocks Moving In Monday's Pre-Market Session

Share:

Gainers

Equillium, Inc. (NASDAQ:EQ) shares rose 261.12% to $11.52 during Monday's pre-market session.

electroCore, Inc. (NASDAQ:ECOR) stock increased by 184.70% to $2.42.

Altimmune, Inc. (NASDAQ:ALT) shares moved upwards by 49.88% to $33.50.

Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) stock rose 17.04% to $3.09. The most recent rating by Mizuho, on Apr 23, is at Buy, with a price target of $14.

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) shares increased by 12.62% to $0.31. According to the most recent rating by Oppenheimer, on Jun 24, the current rating is at Perform.

Centogene, Inc. (NASDAQ:CNTG) shares increased by 8.57% to $14.44. The most recent rating by Baird, on Apr 24, is at Outperform, with a price target of $20.

Cassava Sciences, Inc. (NASDAQ:SAVA) shares rose 8.54% to $3.62. According to the most recent rating by HC Wainwright & Co., on May 18, the current rating is at Neutral.

BioNTech, Inc. (NASDAQ:BNTX) stock moved upwards by 7.73% to $75.80. The most recent rating by SVB Leerink, on Jul 2, is at Market Perform, with a price target of $42.

Tonix Pharmaceuticals, Inc. (NASDAQ:TNXP) stock moved upwards by 7.56% to $0.69.

Seres Therapeutics, Inc. (NASDAQ:MCRB) shares moved upwards by 7.53% to $4.85.

 

Losers

NextCure, Inc. (NASDAQ:NXTC) stock declined 10.52% to $16 during Monday's pre-market session. According to the most recent rating by Benchmark, on Jun 1, the current rating is at Hold.

Endologix, Inc. (NASDAQ:ELGX) shares decreased by 5.56% to $0.26. According to the most recent rating by BTIG, on May 12, the current rating is at Neutral.

Mesoblast, Inc. (NASDAQ:MESO) stock declined 3.85% to $12.52. The most recent rating by HC Wainwright & Co., on May 28, is at Buy, with a price target of $21.

Dynatronics, Inc. (NASDAQ:DYNT) shares decreased by 3.49% to $0.83. The most recent rating by Aegis Capital, on May 19, is at Buy, with a price target of $1.

9 Meters Biopharma, Inc. (NASDAQ:NMTR) shares decreased by 3.40% to $0.53.

CHF Solutions, Inc. (NASDAQ:CHFS) stock declined 3.31% to $0.59.

Arbutus Biopharma, Inc. (NASDAQ:ABUS) stock declined 3.23% to $1.80. The most recent rating by Wedbush, on May 19, is at Outperform, with a price target of $4.

 

Related Articles (EQ + ECOR)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversPre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com